Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LURASIDONE HYDROCHLORIDE
- Cannabidiol for Bipolar Depression (CBD-BD)
- Vortioxetine Adjunctive Treatment in Bipolar Depression
- Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU)
- The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine
- The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia
- Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients
- A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression
- 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder
- Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
- A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
- A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia
- NRX101 Glx Biomarker Validation Study
- NRX101 Glx Biomarker Validation Study
- NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
- NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation
- NRX101 for Moderate Bipolar Depression and Suicidal Ideation
- A Study of Lurasidone HCl in Subjects With Schizophrenia
- Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia
- Sequential Therapy for the Treatment of Severe Bipolar Depression.
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients
- Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
- Biosignatures of Latuda for Bipolar Depression
- Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
- Lurasidone Effects on Tissue Glutamate in Schizophrenia
- Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects
- A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects
- Lurasidone and Cognition in Bipolar I Disorder
- Lurasidone Pediatric Bipolar Study
- A Clinical Trial of Lurasidone in Treatment of Schizophrenia
- A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.
- A Phase III Study of SM-13496 in Patients With Bipolar I Depression.
- A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone
- Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old
- Pediatric Open-Label Extension Study
- Lurasidone Pediatric Autism Study
- Pediatric Schizophrenia Efficacy and Safety Study
- Lurasidone Low-Dose - High-Dose Study Study
- Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
- Pioglitazone for the Treatment of Bipolar Depression
- Lurasidone Pediatric Pharmacokinetics Study
- Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
- A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
- This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder
- High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia
- A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
- Lurasidone Extended Use Study
- PEARL Schizophrenia Maintenance
- Major Depressive Disorder With Mixed Features - Extension
- Major Depressive Disorder With Mixed Features
- Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
- Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
- Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression
- Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
- A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
- A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
- Digoxin Drug-Drug Interaction With Lurasidone HCl
- Rifampin Drug-Drug Interaction Study With Lurasidone HCl
- Midazolam Drug-Drug Interaction Study With Lurasidone HCl
- The Bioequivalence Of Two Different Lurasidone Formulations In Patients
- RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE
- Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl
- Lithium Drug-Drug Interaction Study With Lurasidone HCl
- Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
- Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
- Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
- Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia
- Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
- Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia
- Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia
- Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia
- A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects
- A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
- A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia
- Safety and Tolerability Study of Drug to Treat Schizophrenia
Clinical trials list
click for details